Lara Smrdel

Lara Smrdel
no.: 55140 source: ARIS

researcher – active in research organisation
  lara.smrdelat signffa.uni-lj.si
Edit
Research activity

Code Science Field Subfield
1.09.00  Natural sciences and mathematics  Pharmacy   
Bibliography Representative bibliographic units | Personal | COBISS+
source: COBISS
source: SICRIS
Evaluation (metodology)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
86
A''
0
A'
25.44
A1/2
73.1
CI10
3
CImax
3
h10
1
A1
0.3
A3
0
Data for the last 5 years (citations for the last 10 years) on October 15, 2025; Data for score A3 calculation refer to period 2020-2024
Data for ARIS tenders ( 23.05.2022 – Target research programmes, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 4  7  3  0.75 
Scopus 4  8  3  0.75 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
2nd cycle master's degree      SI University of Ljubljana, Faculty of Pharmacy 2020 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position Role Title
Full time employment (120%, RD:70%)  University of Ljubljana, Faculty of Pharmacy  Chair for Pharmaceutical Chemistry  12/7/2020  Researcher  Researcher  Researcher 
Research projects Legend
source: ARIS
no. Code Title Period Head
1. N1-0417  Mono- and multivalent inhibitors of galectin-8 in tumour-associated (lymph)angiogenesis (MULTIGAL-8)   3/1/2025 - 9/30/2028  PhD Marko Anderluh   824 
2. J3-60066  Advanced post-neoadjuvant treatment of early triple negative breast cancer (TNBC) with autologous cell immunotherapy   1/1/2025 - 12/31/2027  PhD Simona Borštnar   2,849 
3. J3-50116  Matters of the heart: elucidating the cardiotoxic mechanism of proteasome inhibitors   10/1/2023 - 9/30/2026  PhD Martina Gobec   2,431 
4. J3-4496  Next-generation adjuvants for mucosal vaccines   10/1/2022 - 9/30/2025  PhD Žiga Jakopin   1,414 
5. J3-3062  Autologous immunohybridomas and advanced treatment of stage II and III triple-negative breast cancer   10/1/2021 - 9/30/2025  PhD Matjaž Jeras   2,710 
6. J3-1745  Elucidating the role of immunoproteasome in platelet-driven immune response   7/1/2019 - 6/30/2023  PhD Martina Gobec   1,242 
7. NC-0009  Development of new carbamate-based imaging probes for cholinesterases   4/1/2019 - 3/31/2021  PhD Stanislav Gobec   1,144 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head
1. P1-0420  Advanced immunological drugs and cell-based approaches in pharmacy   1/1/2022 - 12/31/2027 PhD Žiga Jakopin   1,410 
Confirmation required
Views history
Favourite